Adrenomed Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
18
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$774K
- Investors
-
10
Adrenomed General Information
Description
Developer of clinical-stage pharmaceutical products designed to improve vascular integrity. The company's products use biomarker-guided monoclonal antibody therapies that offer a causative, safe treatment for acute circulatory failure, enabling doctors to reduce vascular leakage, stabilize the circulation, and lower mortality.
Contact Information
Website
www.adrenomed.comCorporate Office
- Neuendorfstraße 15A
- 16761 Hennigsdorf
- Germany
Corporate Office
- Neuendorfstraße 15A
- 16761 Hennigsdorf
- Germany
Adrenomed Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 01-May-2025 | $774K | Completed | Clinical Trials - Phase 2 | ||
| 5. Later Stage VC | 05-Jul-2022 | Completed | Clinical Trials - Phase 2 | |||
| 4. Later Stage VC | 30-Aug-2021 | Completed | Clinical Trials - Phase 2 | |||
| 3. Later Stage VC (Series E) | 23-Mar-2021 | Completed | Clinical Trials - Phase 2 | |||
| 2. Later Stage VC (Series D) | 17-Jun-2020 | $30.2M | $30.2M | Completed | Clinical Trials - Phase 2 | |
| 1. Later Stage VC | 01-Jan-2014 | Completed | Clinical Trials - Phase 2 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Adrenomed Comparisons
Industry
Financing
Details
Adrenomed Competitors (57)
One of Adrenomed’s 57 competitors is Agomab Therapeutics, a Formerly VC-backed company based in Antwerp, Belgium.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Agomab Therapeutics | Formerly VC-backed | Antwerp, Belgium | ||||
| Virometix | Venture Capital-Backed | Schlieren, Switzerland | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| NGM Biopharmaceuticals | Private Equity-Backed | South San Francisco, CA | ||||
| Abivax | Formerly PE-Backed | Paris, France |
Adrenomed Patents
Adrenomed Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4345109-A1 | Anti-adrenomedullin (adm) binder for use in therapy of pediatric patients with congenital heart disease | Inactive | 30-Sep-2022 | ||
| AU-2023313376-A1 | Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy or prevention of shock | Pending | 29-Jul-2022 | ||
| EP-4562035-A1 | Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy or prevention of shock | Pending | 29-Jul-2022 | ||
| US-20260167706-A1 | Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy or prevention of shock | Pending | 29-Jul-2022 | ||
| WO-2024023369-A1 | Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy or prevention of shock | Inactive | 29-Jul-2022 | C07K16/22 |
Adrenomed Signals
Adrenomed Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| VU Venture Partners | Venture Capital | Minority | ||
| HINKEL & Cie | Corporation | Minority | ||
| Deutsche Biotech Innovativ | Corporation | Minority | ||
| HBM Healthcare Investments | Venture Capital | Minority | ||
| HBM Partners | Venture Capital | Minority |
Adrenomed FAQs
-
When was Adrenomed founded?
Adrenomed was founded in 2009.
-
Where is Adrenomed headquartered?
Adrenomed is headquartered in Hennigsdorf, Germany.
-
What is the size of Adrenomed?
Adrenomed has 18 total employees.
-
What industry is Adrenomed in?
Adrenomed’s primary industry is Drug Discovery.
-
Is Adrenomed a private or public company?
Adrenomed is a Private company.
-
What is Adrenomed’s current revenue?
The current revenue for Adrenomed is .
-
How much funding has Adrenomed raised over time?
Adrenomed has raised $61.3M.
-
Who are Adrenomed’s investors?
VU Venture Partners, HINKEL & Cie, Deutsche Biotech Innovativ, HBM Healthcare Investments, and HBM Partners are 5 of 10 investors who have invested in Adrenomed.
-
Who are Adrenomed’s competitors?
Agomab Therapeutics, Virometix, Inovio Pharmaceuticals, NGM Biopharmaceuticals, and Abivax are some of the 57 competitors of Adrenomed.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process